| Literature DB >> 23554676 |
Liang Zong1, Ping Chen, Yinbing Chen, Guohao Shi.
Abstract
After a total resection of the stomach, the continuity of the gastrointestinal tract can be restored either by Roux-en-Y esophagojejunostomy with or without a pouch. There is still no consensus on the best reconstruction technique. The aim of this report was to derive a more precise estimation of Roux-en-Y esophagojejunostomy with a pouch compared with Roux-en-Y esophagojejunostomy without a pouch. Studies were identified by PubMed and Embase searches, and the inclusion criteria were randomized controlled trials (RCTs) comparing reconstruction techniques between Roux-en-Y with and without a pouch. A total of 12 studies including 1,018 patients were included. The meta-analysis shows that pouch Roux-en-Y does not significantly increase total postoperative complications, anastomotic leakage or mortality. Importantly, there is no significant difference in 5-year survival rates between the two groups. Patients with Roux-en-Y esophagojejunostomy complained significantly less of reflux symptoms and dumping syndrome, and had significantly less severe reflux esophagitis. Quality of life was significantly improved in patients with Roux-en-Y esophagojejunostomy with a pouch compared with patients who received Roux-en-Y reconstruction without a pouch. The results indicate the need for Roux-en-Y esophagojejunostomy with a pouch is a gastric substitute after total gastrectomy by comparison with Roux-en-Y esophagojejunostomy without a pouch.Entities:
Keywords: gastric cancer; meta-analysis; reconstruction; total gastrectomy
Year: 2011 PMID: 23554676 PMCID: PMC3596699 DOI: 10.1016/S1674-8301(11)60011-0
Source DB: PubMed Journal: J Biomed Res ISSN: 1674-8301
Main characteristics of studies included
| RCT | Reconstruction | Reflux symptoms | Dumping Syndrome | Esophagitis | Postoperative complications | Anastomotic leakage | Mortality | 5-year survival | |
| Wei HB | P-RY | 63 | NA | NA | 3 | 7 | NA | 1 | NA |
| 2008 | RY | 155 | NA | NA | 5 | 12 | NA | 3 | NA |
| Fein M | J-RY | 71 | NA | NA | NA | 22 | 8 | 9 | NA |
| 2008 | RY | 67 | NA | NA | NA | 21 | 6 | 7 | NA |
| Kalmar K | Aboral-RY | 22 | NA | NA | NA | NA | NA | NA | NA |
| 2001 | RY | 18 | NA | NA | NA | NA | NA | NA | NA |
| Fuchs KH | J-RY | 53 | NA | NA | NA | 13 | 5 | 2 | 29 |
| 1995 | RY | 14 | NA | NA | NA | 4 | 0 | 1 | NA |
| Hirao M | P-RY | 35 | NA | NA | NA | 5 | NA | 0 | NA |
| 2009 | RY | 35 | NA | NA | NA | 5 | NA | 0 | NA |
| Bozzetti F | P-RY | 23 | NA | 0/15 | NA | 6 | NA | NA | NA |
| 1996 | RY | 23 | NA | 1/12 | NA | 2 | NA | NA | NA |
| Paimela H | J-RY | 155 | NA | NA | NA | 30 | 7 | NA | 50-41 |
| 2005 | RY | 116 | NA | NA | NA | 13 | 1 | NA | 34-22 |
| Nozoe T | J-IP | 14 | 1 | NA | NA | NA | 0 | NA | NA |
| 2001 | RY | 16 | 3 | NA | NA | NA | 1 | NA | NA |
| Adachi S | P-RY | 10 | 1 | 0 | NA | 2 | 0 | NA | NA |
| 2003 | RY | 10 | 6 | 2 | NA | 2 | 0 | NA | NA |
| Kono K | P-RY | 23 | NA | NA | 0 | 2 | 0 | NA | NA |
| 2003 | RY | 24 | NA | NA | 1 | 0 | 0 | NA | NA |
| Nakane Y | P-RY | 10 | 3 | 0 | NA | 2 | 0 | NA | NA |
| 1995 | RY | 10 | 3 | 1 | NA | 2 | 0 | NA | NA |
| Iivonen MK | P-RY | 27 | 11/24 | 7/24 | NA | NA | 1/27 | NA | 15/27 |
| 1999-2000 | RY | 24 | 9/21 | 11/21 | NA | NA | 1/24 | NA | 14/24 |
RCT: randomized controlled trial; P-RY: Pouch Roux-en-Y; RY: Roux-en-Y; NA: not available; J-RY: Jejunal Pouch Roux-en-Y; J-IP: Jejunal Interposition Pouch.
Main Characteristics of studies included (continued)
| RCT | Reconstruction | Operation time (min) | Blood loss (mL) | Hospital stay (d) | Eating capacity in normal size | Albumin(g/L) | Mortality | |
| Wei HB | P-type | 63 | 204±12 | NA | NA | NA | 38.76 ± 3.41 | NA |
| 2008 | Orr-type | 155 | 174±6 | NA | NA | NA | 39.32 ± 3.30 | NA |
| Fein M | J-RY | 71 | NA | NA | NA | 5/17 | NA | 97.6 ± 23.6 |
| 2008 | RY | 67 | NA | NA | NA | 5/17 | NA | 93.6 ± 23.2 |
| Kalmar K | Aboral-RY | 22 | NA | NA | NA | NA | 40.70 ± 3.11 | 105.9 ± 3.03 |
| 2001 | RY | 18 | NA | NA | NA | NA | 39.76 ± 3.56 | 96.5 ± 4.12 |
| Fuchs K-H | J-RY | 53 | NA | NA | NA | NA | NA | NA |
| 1995 | RY | 14 | NA | NA | NA | NA | NA | NA |
| Hirao M | P-RY | 35 | NA | NA | NA | NA | NA | NA |
| 2009 | RY | 35 | NA | NA | NA | NA | NA | NA |
| Bozzetti F | P-RY | 23 | NA | NA | NA | NA | NA | NA |
| 1996 | RY | 23 | NA | NA | NA | NA | NA | NA |
| Paimela H | J-RY | 155 | 171 ± 9 | 700 ± 100 | 14 ± 1 | NA | NA | NA |
| 2005 | RY | 116 | 143 ± 8 | 500 ± 100 | 17 ± 2 | NA | NA | NA |
| Nozoe T | J-IP | 14 | 310 ± 91 | 702 ± 261 | NA | NA | NA | NA |
| 2001 | RY | 16 | 301 ± 75 | 568 ± 433 | NA | NA | NA | NA |
| Adachi S | P-RY | 10 | 259±43 | 678 ± 409 | 27 ± 6 | NA | NA | NA |
| 2003 | RY | 10 | 272 ± 60 | 552 ± 255 | 33 ± 8 | NA | NA | NA |
| Kono K | P-RY | 23 | 242 ± 28 | 445 ± 99 | NA | NA | NA | NA |
| 2003 | RY | 24 | 230 ± 34 | 499 ± 105 | NA | NA | NA | NA |
| Iivonen MK | P-RY | 24 | NA | NA | NA | 19/24 | NA | NA |
| 1999-2000 | RY | 21 | NA | NA | NA | 3/21 | NA | NA |
P-type: P type Roux-en-Y; Orr-type: Orr type Roux-en-Y; J-RY: Jejunal Pouch Roux-en-Y; RY: Roux-en-Y; P-RY: Pouch Roux-en-Y; NA: not available.
Fig. 1Meta-analyses of parameters of the postoperative course.
A: Total postoperative complications. B: Anastomotic leakage. C: Mortality. D: 5-year survival.
Fig. 2Meta-analyses of parameters of the quality of life.
A: Reflux symptoms. B: Dumping syndrome. C: Reflux esophagitis. D: Eating capacity. E: Serum albumin. F: Quality of life index.
Fig. 3Meta-analyses of parameters of general data of operation.
A: Operation time. B: Blood loss. C: Hospital stay.
Fig. 4The publieation bias of the retrived literature (Pouch Roux-en-Y vs No Pouch)
A: Postoperative complications. B: Anastomotic leakage. C: Mortalty. D: 5-year survival. E: Reflux symptom. F: Dumping syndrome. G: Rellux esophagitie. H: Eating capacity in normal size. I: Serum Albumin. J: Quality of Life Index. K: Operation time. L: Blood loss. M: Hospital stay.